Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. provides omni-channel pharmaceutical distribution services in China. It is involved in pharmaceutical B2B e-commerce, production, wholesale, and retail businesses, as well as provides logistics services. It offers Western medicine, Chinese patent medicine, Chinese herbal medicine slices and Chinese medicinal materials, food and health f… Read more
Market Cap & Net Worth: Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937)
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (SHE:300937) has a market capitalization of $404.19 Million (CN¥2.97 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #15832 globally and #4220 in its home market, demonstrating a -1.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s stock price CN¥31.00 by its total outstanding shares 95666682 (95.67 Million).
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. Market Cap History: 2021 to 2026
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows change from $584.32 Million to $404.19 Million (-4.45% CAGR).
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s market cap is 0.07 times its annual revenue
7.95x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
19.94x
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s market cap is 19.94 times its annual earnings
1.77x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $584.32 Million | $3.40 Billion | $6.40 Million | 0.17x | 91.30x |
| 2022 | $370.22 Million | $3.97 Billion | $42.02 Million | 0.09x | 8.81x |
| 2023 | $405.97 Million | $4.43 Billion | $59.53 Million | 0.09x | 6.82x |
| 2024 | $326.22 Million | $4.38 Billion | $16.36 Million | 0.07x | 19.94x |
Competitor Companies of 300937 by Market Capitalization
Companies near Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.'s market cap moved from $584.32 Million to $ 404.19 Million, with a yearly change of -4.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥404.19 Million | -9.06% |
| 2025 | CN¥444.48 Million | +36.25% |
| 2024 | CN¥326.22 Million | -19.64% |
| 2023 | CN¥405.97 Million | +9.66% |
| 2022 | CN¥370.22 Million | -36.64% |
| 2021 | CN¥584.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $404.19 Million USD |
| MoneyControl | $404.19 Million USD |
| MarketWatch | $404.19 Million USD |
| marketcap.company | $404.19 Million USD |
| Reuters | $404.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.